These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 22969224)
1. Management of chronic hepatitis B in pregnancy. Han GR; Xu CL; Zhao W; Yang YF World J Gastroenterol; 2012 Sep; 18(33):4517-21. PubMed ID: 22969224 [TBL] [Abstract][Full Text] [Related]
2. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. ; Dionne-Odom J; Tita AT; Silverman NS Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123 [TBL] [Abstract][Full Text] [Related]
3. Management of Chronic Hepatitis B in Pregnancy. Li J; Chang MS; Tran TT; Nguyen MH J Clin Gastroenterol; 2017 Oct; 51(9):789-795. PubMed ID: 28816860 [TBL] [Abstract][Full Text] [Related]
5. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206 [TBL] [Abstract][Full Text] [Related]
6. [Consensus on clinical management of hepatitis B virus- infected women of childbearing age]. Chinese Society of Hepatology, Chinese Medical Association Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):204-208. PubMed ID: 29804394 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Tavakolpour S; Darvishi M; Mirsafaei HS; Ghasemiadl M Infect Dis (Lond); 2018 Feb; 50(2):95-106. PubMed ID: 29020844 [TBL] [Abstract][Full Text] [Related]
8. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission]. Yin YZ; Zhou J; Zhang PZ; Hou HY Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881 [TBL] [Abstract][Full Text] [Related]
9. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus. Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads. Xu J; Tao LL; Ma LX J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789 [No Abstract] [Full Text] [Related]
12. Optimal management of HBV infection during pregnancy. Piratvisuth T Liver Int; 2013 Feb; 33 Suppl 1():188-94. PubMed ID: 23286864 [TBL] [Abstract][Full Text] [Related]
13. Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission. Chen HL; Wen WH; Chang MH J Infect Dis; 2017 Nov; 216(suppl_8):S785-S791. PubMed ID: 29156049 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission. Chamroonkul N; Piratvisuth T Paediatr Drugs; 2017 Jun; 19(3):173-181. PubMed ID: 28434087 [TBL] [Abstract][Full Text] [Related]
15. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus. Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007 [TBL] [Abstract][Full Text] [Related]
16. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL; Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463 [TBL] [Abstract][Full Text] [Related]
17. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. Yoo ER; Perumpail RB; Cholankeril G; Ahmed A BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27852658 [TBL] [Abstract][Full Text] [Related]
18. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge]. Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336 [TBL] [Abstract][Full Text] [Related]
19. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up. Joshi SS; Gao S; Castillo E; Coffin CS Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084 [TBL] [Abstract][Full Text] [Related]